The OMERACT way for domain selection involves a systematic and collaborative approach for identifying and selecting domains (i.e., aspects of health and disease) that are important to patients, healthcare providers, and researchers for measuring outcomes in rheumatologic conditions. The following are the steps involved in the OMERACT way for domain selection: Identify relevant stakeholders: The first step is to identify and engage relevant stakeholders, including patients, healthcare providers, researchers, and others who have a vested interest in the outcomes being measured. Develop a preliminary list of domains: Based on input from stakeholders, a preliminary list of potential domains is developed. This list should include all possible domains that may be relevant for measuring outcomes in the particular rheumatologic condition being studied. Prioritize the domains: Using a structured and transparent process, stakeholders prioritize the domains based on their importance and relevance to patients, healthcare providers, and researchers. This may involve using techniques such as Delphi surveys or nominal group techniques. Refine the list of domains: Based on the prioritization results, the list of domains is refined to include only those domains that are considered most important and relevant for measuring outcomes in the specific rheumatologic condition being studied. Test the domains: The final step is to test the domains for their validity, reliability, and responsiveness. This involves evaluating how well the selected domains measure the outcomes that they are intended to measure, and ensuring that they are consistently and accurately measured across different settings and populations. By following the OMERACT way for domain selection, researchers and healthcare providers can identify and measure the outcomes that matter most to patients with rheumatologic conditions. This can help to improve the quality of care and outcomes for patients, and ensure that research is focused on the outcomes that are most relevant and meaningful to patients and other stakeholders.

Scroll to Top